Anjali Seth studied Physics and Chemistry in Paris. She obtained her PhD from Pierre and Marie Curie University for her research on magnetic nanoparticles for targeted drug delivery and imaging. She then moved to Oxford, UK, for a postdoctoral project on magnetic particles and ultrasound for cancer theranostics. In 2019, she joined Cellenion, a company specialized in the field of single-cell isolation, to develop and lead the single cell proteomics R&D department. Since then, she had the opportunity to participate in the advancement of the cutting-edge field of single cell proteomics analyses using mass spectrometry. In Cellenion, she focuses on developing tools to facilitate and automate sample preparation workflows prior to analysis. Cellenion is now collaborating with most of the key opinion leader in the field.